ArticleThe Kaohsiung journal of medical sciences2025
The Relationship Between Serum SFRP5, ApoA-I, HDL3-C Level and In-Stent Restenosis After PCI in Acute Myocardial Infarction and the Combined Predictive Value.
Article in The Kaohsiung journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to investigate the relationship between serum secreted frizzled-related protein 5 (SFRP5), apolipoprotein A-I (ApoA-I), high-density lipoprotein 3-cholesterol (HDL3-C) and in-stent restenosis (ISR) after percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) and their combined predictive value. The clinical data of 128 AMI patients who underwent PCI in our hospital from July 2020 to July 2023 were retrospectively analyzed. After 12 months of follow-up, the patients were divided into the ISR group (24 cases) and the non-ISR group (104 cases) according to the results of coronary angiography. The 24 patients with ISR were divided into Grade III (lumen stenosis area of 50%-70%, 15 cases) and Grade IV (lumen stenosis area of 76%-100%, 9 cases). The general data of the two groups were compared. The serum levels of SFRP5, ApoA-I, and HDL3-C in the two groups were analyzed on the second day after the operation. The levels of SFRP5, ApoA-I, and HDL3-C in patients with different degrees of stenosis were compared. The correlation between serum SFRP5, ApoA-I, HDL3-C levels and ISR after PCI was analyzed by bivariate correlation Kendall tau-b (K). Logistic regression was used to analyze the influencing factors of ISR after PCI. The receiver operating characteristic (ROC) curve was drawn to analyze the predictive value of SFRP5, ApoA-I, and HDL3-C in ISR after PCI. The proportion of patients with diabetes and a smoking history in the ISR group was higher than that in the non-ISR group. The stent length (29.52 ± 5.47 mm) and hs-CRP level (3.38 ± 0.51 mg/L) in the ISR group were higher than those in the non-ISR group (23.56 ± 5.37 mm and 2.78 ± 0.52 mg/L) (p < 0.05). SFRP5 (15.33 ± 2.60 ng/mL), ApoA-I (1.22 ± 0.37 g/L) and HDL3-C (0.31 ± 0.07 mmol/L) in the ISR group were higher than those in the non-ISR group (19.79 ± 3.09 ng/mL, 1.77 ± 0.41 g/L, and 0.46 ± 0.11 mmol/L) (p < 0.001). The levels of SFRP5 (17.57 ± 2.57 ng/mL), ApoA-I (1.56 ± 0.34 g/L) and HDL3-C (0.36 ± 0.07 mmol/L) in the Grade III group were higher than those in the Grade IV group (13.15 ± 2.35 ng/mL, 0.98 ± 0.20 g/L, and 0.25 ± 0.05 mmol/L) (p < 0.05). The results of bivariate correlation Kendall tau-b (K) analysis showed that the levels of serum SFRP5, ApoA-I, and HDL3-C were negatively correlated with ISR (r < 0, p < 0.05). Logistic regression analysis showed that diabetes and hs-CRP were risk factors for ISR after PCI (OR > 1, p < 0.05). SFRP5, ApoA-I, and HDL3-C were protective factors for ISR after PCI (OR < 1, p < 0.05). The ROC curve showed that the AUC of SFRP5, ApoA-I, and HDL3-C levels alone and in combination to predict ISR in AMI patients after PCI was > 0.70, which had certain predictive value, and the combined value was higher. In conclusion, diabetes and high levels of hs-CRP were risk factors for ISR in patients with AMI after PCI. High levels of SFRP5, ApoA-I, and HDL3-C were protective factors for ISR after PCI, and their combined detection had certain value in predicting ISR after PCI. This would provide guidance strategy for clinical timely intervention measures to reduce the occurrence of ISR in AMI patients after PCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.